Orchestrating the Immune System

Mozart is developing CD8 T cell immune modulators for the treatment of autoimmune diseases.


Founded on seminal work from leading scientists, Mozart is developing biologics to target a novel T cell network of pathogenic CD4 and cytolytic-regulatory CD8 T cells. We are taking a new approach to establish immune balance to make a meaningful difference in the lives of patients.